Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H H, Doody, R S, Kivipelto, M, Sparks, D L, Waters, D D, Jones, R W, Schwam, E, Schindler, R, Hey-Hadavi, J, DeMicco, D A, Breazna, A
Published in Neurology (23.03.2010)
Published in Neurology (23.03.2010)
Get more information
Journal Article
Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study
Deedwania, P. C., Shepherd, J., Breazna, A., DeMicco, D. A.
Published in Diabetes, obesity & metabolism (01.01.2016)
Published in Diabetes, obesity & metabolism (01.01.2016)
Get full text
Journal Article
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
Chaturvedi, S, Zivin, J, Breazna, A, Amarenco, P, Callahan, A, Goldstein, L B, Hennerici, M, Sillesen, H, Rudolph, A, Welch, M A
Published in Neurology (24.02.2009)
Published in Neurology (24.02.2009)
Get more information
Journal Article
Effect of high‐dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the T reating to N ew T argets ( TNT ) study
Deedwania, P. C., Shepherd, J., Breazna, A., DeMicco, D. A.
Published in Diabetes, obesity & metabolism (01.01.2016)
Published in Diabetes, obesity & metabolism (01.01.2016)
Get full text
Journal Article
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study
Grill, Jacques, Geoerger, Birgit, Gesner, Lyle, Perek, Danuta, Leblond, Pierre, Cañete, Adela, Aerts, Isabelle, Madero, Luis, de Toledo Codina, Josep Sanchez, Verlooy, Joris, Estlin, Edward, Cisar, Laura, Breazna, Aurora, Dorman, Andrew, Bailey, Simon, Nicolin, Gary, Grundy, Richard G, Hargrave, Darren
Published in Neuro-oncology (Charlottesville, Va.) (01.09.2013)
Published in Neuro-oncology (Charlottesville, Va.) (01.09.2013)
Get full text
Journal Article
100O Results of A Randomized Phase 2 Study of Pd 0332991, A Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, In Combination with Letrozole vs Letrozole Alone For First-Line Treatment of ER + /Her2- Advanced Breast Cancer (Bc)
Finn, R.S., Crown, J.P., Boer, K., Lang, I., Parikh, R.J., Breazna, A., Ho, S.N., Kim, S.T., Randolph, S., Slamon, D.J.
Published in Annals of oncology (01.05.2012)
Published in Annals of oncology (01.05.2012)
Get full text
Journal Article
Phase I, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of single-agent PF-03758309, an oral PAK inhibitor, in patients with advanced solid tumors
Mileshkin, L. R., Rosen, L. S., Blumenkopf, T., Breazna, A., Darang, S., Davison, J., Gallo, J., Goldman, J. W., Wang, D. D., Zhang, S., Eckhardt, S. G.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics
Jones, Roy W, Kivipelto, Miia, Feldman, Howard, Sparks, Larry, Doody, Rachelle, Waters, David D, Hey-Hadavi, Judith, Breazna, Andrei, Schindler, Rachel J, Ramos, Harry
Published in Alzheimer's & dementia (01.03.2008)
Published in Alzheimer's & dementia (01.03.2008)
Get full text
Journal Article
Abstract S1-6: Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (BC)
Finn, RS, Crown, JP, Lang, I, Boer, K, Bondarenko, IM, Kulyk, SO, Ettl, J, Patel, R, Pinter, T, Schmidt, M, Shparyk, Y, Thummala, AR, Voytko, NL, Breazna, A, Kim, ST, Randolph, S, Slamon, DJ
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Pharmacodynamically guided dose selection of PF-00337210, a VEGFR2 tyrosine kinase (TK) inhibitor, in a phase I study
Liu, G., LoRusso, P., Heath, E. I., Bruce, J. Y., Traynor, A. M., Pilat, M., Breazna, A., Tortorici, M., Shalinsky, D. R., Ricart, A. D.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
P1-17-05: Preliminary Results of a Randomized Phase 2 Study of PD 0332991, a Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor, in Combination with Letrozole for First-Line Treatment of Patients (pts) with Post-Menopausal, ER+, HER2−Negative (HER2–) Advanced Breast Cancer
Finn, RS, Crown, JP, Boer, K, Lang, I, Parikh, RJ, Patel, R, Schmidt, M, Hagenstad, C, Lim, H, Pinter, T, Amadori, D, Chan, D, Dichmann, RA, Walshe, J, Breazna, A, Kim, ST, Randolph, S, Slamon, DJ
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Phase II single-arm study of irinotecan in combination with temozolomide in children with recurrent or refractory medulloblastoma
Grill, J., Perek, D., Sanchez de Toledo-Codina, J., Madero, L., Estlin, E., Cañete, A., Icher, C., Breazna, A., Geoerger, B., Cisar, L., Hargrave, D.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Detailed analysis of survival and safety with sunitinib (SU) in a worldwide treatment-use trial of patients with advanced GIST
Reichardt, P., Kang, Y., Ruka, W., Seddon, B., Guerriero, A., Breazna, A., Lowry, S., Demetri, G. D.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
EFFECT OF INTENSIVE CHOLESTEROL LOWERING WITH ATORVASTATIN 80MG IN PATIENTS WITH PREVIOUS REVASCULARIZATION: A TREATING TO NEW TARGETS (TNT) SUBSTUDY
Waters, D., Johnson, C., Bittner, V., DeMicco, D., Breazna, A., LaRosa, J.
Published in Atherosclerosis. Supplements (01.05.2008)
Published in Atherosclerosis. Supplements (01.05.2008)
Get full text
Journal Article